Aquyre Biosciences, Inc.

What Makes Aquyre Biosciences Different?

Our technology combines two different proprietary technologies in one exam, offering non-invasive, non-destructive, intraprocedural tissue adequacy assessment, in freshly excised tissue, within 2 minutes.

Our Technologies:

– Full-Field Optical Coherence Tomography (FFOCT) offers en face (transverse), high resolution, 3D imaging of the tissue micro-architecture, at a resolution of 1μm. FFOCT also allows for depth exploration at different focal planes, without compromising 1μm resolution.

– Dynamic Cell Imaging (DCI) – enhances the cellular contrast by capturing the residual microscopic intracellular activity and behaviors in freshly excised tissue, without staining or partially destroying the tissue.

Patient Benefits:
– quicker time to results; avoid potential delays waiting for results associated with sending the sample to the lab and waiting days for a report
– avoid potential redo procedures
– avoid potential delays in available treatment options

Clinician Benefits:
– increase the tissue adequacy assessment rate with immediate access to tissue microarchitecture and cellular data at your fingertips
– receiving immediate feedback and information may result in fewer passes and consequently few complications
– creates more consistent workflow efficiencies throughout the day
– improves productivity

Hospital benefits:
– impacts the quality of care by meeting an unmet need in the patient continuum of care
– directly affects patient satisfaction scores
– a direct impact on costs (ie- unnecessary redo procedures, wasted procedure suite/operating room time, etc.)
– a positive effect on patient throughput where there are already constraints by labor shortages and physical resources

Today’s Mission: become the standard of care for tissue adequacy assessment

Company’s Keywords:

digital pathology, radiology, interventional pulmonology, biomedical diagnostics, medical imaging, bio banking, urology, breast surgery, liver surgery, lung cancer, breast cancer, liver cancer, prostate cancer, prostate surgery